Cargando…
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies
RATIONALE: The growing prevalence of psychostimulant (including amphetamine) use and associated health harms, with limited treatment options, present a global challenge. There is an increasing availability and medical applications of cannabinoids, and growing interest in their therapeutic potential...
Autores principales: | Daldegan-Bueno, Dimitri, Maia, Lucas O., Glass, Michelle, Jutras-Aswad, Didier, Fischer, Benedikt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110457/ https://www.ncbi.nlm.nih.gov/pubmed/34613429 http://dx.doi.org/10.1007/s00213-021-05960-2 |
Ejemplares similares
-
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators
por: Maia, Lucas O., et al.
Publicado: (2021) -
Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
por: Fischer, Benedikt, et al.
Publicado: (2023) -
Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada)
por: Fischer, Benedikt, et al.
Publicado: (2020) -
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations
por: Fischer, Benedikt, et al.
Publicado: (2020) -
Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review
por: Kaur, Navdeep, et al.
Publicado: (2022)